Trench fever is a louse-borne Bartonella quintana infection transmitted when feces from infected human body lice contaminate broken skin. B. quintana colonizes erythrocytes to produce persistent bacteremia and a spectrum that includes endocarditis, chronic lymphadenopathy, and, especially in immunocompromised hosts, vasoproliferative bacillary angiomatosis.
Ask a research question about Trench Fever. OpenScientist will conduct autonomous deep research using the Disorder Mechanisms Knowledge Base and PubMed literature (typically 10-30 minutes).
Do not include personal health information in your question. Questions and results are cached in your browser's local storage.
name: Trench Fever
creation_date: '2026-09-25T00:00:00Z'
category: Infectious Disease
description: >-
Trench fever is a louse-borne Bartonella quintana infection transmitted when
feces from infected human body lice contaminate broken skin. B. quintana
colonizes erythrocytes to produce persistent bacteremia and a spectrum that
includes endocarditis, chronic lymphadenopathy, and, especially in
immunocompromised hosts, vasoproliferative bacillary angiomatosis.
disease_term:
preferred_term: trench fever
term:
id: MONDO:0005991
label: trench fever
parents:
- Bacterial Infection
- Vector-borne disease
synonyms:
- Five-day fever
- Quintan fever
- Shin bone fever
- His-Werner disease
- Wolhynia fever
- Urban trench fever
classifications:
harrisons_chapter:
- classification_value: INFECTIOUS_DISEASES
infectious_agent:
- name: Bartonella quintana
description: >-
Human-restricted, louse-vectored Gram-negative Bartonella species that causes
trench fever, chronic bacteremia, endocarditis, and bacillary angiomatosis.
infectious_agent_term:
preferred_term: Bartonella quintana
term:
id: NCBITaxon:803
label: Bartonella quintana
evidence:
- reference: PMID:16494745
reference_title: Bartonella quintana characteristics and clinical management.
supports: SUPPORT
evidence_source: OTHER
snippet: >-
Bartonella quintana, a pathogen that is restricted to human hosts and louse
vectors, was first characterized as the agent of trench fever.
explanation: >-
This review identifies B. quintana as the human- and louse-associated
bacterial agent of trench fever.
transmission:
- name: Body louse fecal transmission
description: >-
The human body louse acquires B. quintana during blood feeding on a
bacteremic person and passes infectious feces that can be scratched into
broken skin of a new human host.
evidence:
- reference: PMID:35803580
reference_title: >-
Examination of vertical transmission of Bartonella quintana in body lice
following multiple infectious blood meals.
supports: SUPPORT
evidence_source: MODEL_ORGANISM
snippet: >-
Horizontal transmission from the body louse vector (Pediculus humanus
humanus) to a human host occurs through contact with infectious louse feces
containing a high concentration of the bacteria.
explanation: >-
Body-louse infection experiments describe feces-mediated horizontal
transmission as the route to humans.
environmental:
- name: Body louse infestation and homelessness
description: >-
Human body louse infestation - associated with homelessness, poverty, and
poor hygiene - is the environmental context that supplies
the louse vector for B. quintana, and urban trench fever is a reemerging
disease of homeless populations.
influences_mechanisms:
- target: Body-Louse Fecal Bartonella Inoculation
environmental_effect: PREDISPOSES
causal_link_type: DIRECT
description: >-
Louse infestation in homeless, impoverished settings supplies the body-louse
vector whose infectious feces inoculate B. quintana.
evidence:
- reference: PMID:16494745
reference_title: Bartonella quintana characteristics and clinical management.
supports: SUPPORT
evidence_source: OTHER
snippet: >-
It is now recognized as a reemerging pathogen among homeless populations
in cities in the United States and Europe
explanation: B. quintana is a reemerging pathogen of homeless populations, the louse-infested context.
evidence:
- reference: PMID:16494745
reference_title: Bartonella quintana characteristics and clinical management.
supports: SUPPORT
evidence_source: OTHER
snippet: >-
It is now recognized as a reemerging pathogen among homeless populations
in cities in the United States and Europe
explanation: Establishes homelessness/louse infestation as the reemergence context for trench fever.
- reference: PMID:16494745
reference_title: Bartonella quintana characteristics and clinical management.
supports: SUPPORT
evidence_source: OTHER
snippet: >-
which lives in clothes (Figure 2) and is associated with poverty, lack of
hygiene, and cold weather
explanation: The body louse vector is associated with poverty, poor hygiene, and cold weather.
progression:
- phase: Body-louse exposure and fecal inoculation
notes: >-
Infectious louse feces contaminate abrasions or scratch excoriations after
body-louse feeding, initiating human B. quintana infection.
evidence:
- reference: PMID:35803580
reference_title: >-
Examination of vertical transmission of Bartonella quintana in body lice
following multiple infectious blood meals.
supports: SUPPORT
evidence_source: MODEL_ORGANISM
snippet: >-
Horizontal transmission from the body louse vector (Pediculus humanus
humanus) to a human host occurs through contact with infectious louse feces
containing a high concentration of the bacteria.
explanation: >-
Supports infectious-feces exposure as the host-entry phase.
- phase: Persistent bacteremia and systemic complications
notes: >-
After host entry, B. quintana can establish intraerythrocytic bacteremia and
cause chronic bacteremia, culture-negative endocarditis, and
vasoproliferative bacillary angiomatosis.
evidence:
- reference: PMID:16494745
reference_title: Bartonella quintana characteristics and clinical management.
supports: SUPPORT
evidence_source: OTHER
snippet: >-
It is now recognized as a reemerging pathogen among homeless populations in
cities in the United States and Europe and is responsible for a wide
spectrum of conditions, including chronic bacteremia, endocarditis, and
bacillary angiomatosis.
explanation: >-
The review summarizes the principal chronic and vasoproliferative clinical
complications of B. quintana infection.
pathophysiology:
- name: Body-Louse Fecal Bartonella Inoculation
description: >-
Infectious B. quintana shed in human-body-louse feces reaches a new host
through contaminated bite scratches or other skin abrasions.
role: trigger
biological_processes:
- preferred_term: symbiont entry into host
modifier: INCREASED
term:
id: GO:0044409
label: symbiont entry into host
evidence:
- reference: PMID:35803580
reference_title: >-
Examination of vertical transmission of Bartonella quintana in body lice
following multiple infectious blood meals.
supports: SUPPORT
evidence_source: MODEL_ORGANISM
snippet: >-
Horizontal transmission from the body louse vector (Pediculus humanus
humanus) to a human host occurs through contact with infectious louse feces
containing a high concentration of the bacteria.
explanation: >-
Supports fecal inoculation from the body louse as the initiating exposure.
downstream:
- target: Trw-Associated Erythrocyte Colonization
description: >-
Host entry gives B. quintana access to the bloodstream, where Bartonella
Trw type IV secretion machinery supports erythrocyte tropism.
- name: Trw-Associated Erythrocyte Colonization
description: >-
The Bartonella Trw type IV secretion system contributes to host-specific
adhesion to erythrocytes, supporting the long-lasting intraerythrocytic
bacteremia that characterizes B. quintana infection.
cell_types:
- preferred_term: erythrocyte
term:
id: CL:0000232
label: erythrocyte
biological_processes:
- preferred_term: symbiont entry into host cell
modifier: INCREASED
term:
id: GO:0046718
label: symbiont entry into host cell
evidence:
- reference: PMID:20548954
reference_title: >-
The Trw type IV secretion system of Bartonella mediates host-specific
adhesion to erythrocytes.
supports: SUPPORT
evidence_source: MODEL_ORGANISM
snippet: >-
The corresponding genes encode components of the type IV secretion system
(T4SS) Trw, demonstrating that this virulence factor laterally acquired by
the Bartonella lineage is directly involved in adherence to erythrocytes.
explanation: >-
Bartonella mutagenesis and erythrocyte-assay data identify Trw as the
lineage virulence factor that mediates erythrocyte adhesion, the red-cell
colonization step curated here for B. quintana.
downstream:
- target: Acute Febrile Bacteremic Illness
description: >-
Intraerythrocytic bacteremia produces the acute, often relapsing febrile
illness that is the cardinal trench-fever syndrome.
causal_link_type: INDIRECT_KNOWN_INTERMEDIATES
- target: Chronic Bacteremia and Endocarditis
description: >-
Persistent B. quintana bacteremia can remain chronic and seed
blood-culture-negative bacterial endocarditis.
- name: Acute Febrile Bacteremic Illness
description: >-
The classic trench-fever syndrome is an acute bacteremic illness with sudden
headache, pain in the shins, and high fever; a relapsing form with a shorter
initial period and frequent relapses (the "five-day"/quintan periodicity)
was also described.
role: consequence
cell_types:
- preferred_term: erythrocyte
term:
id: CL:0000232
label: erythrocyte
evidence:
- reference: PMID:16494745
reference_title: Bartonella quintana characteristics and clinical management.
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
quote_role: REVIEW_SYNTHESIS
snippet: >-
The first was characterized by a sudden onset of headache, dizziness, pain
in the shins, and elevated temperature
explanation: Describes the classic acute trench-fever syndrome of headache, shin pain, and fever.
- reference: PMID:16494745
reference_title: Bartonella quintana characteristics and clinical management.
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
quote_role: REVIEW_SYNTHESIS
snippet: >-
The second manifestation of the disease was characterized by a shorter
initial period and frequent relapses.
explanation: Describes the relapsing (five-day/quintan) form of trench fever.
downstream:
- target: Fever
description: The acute bacteremic illness produces high fever.
- target: Headache
description: The acute syndrome produces headache.
- target: Bone pain
description: The acute syndrome produces characteristic shin (tibial) bone pain.
- name: Chronic Bacteremia and Endocarditis
description: >-
Long-lasting B. quintana bacteremia is the systemic reservoir that produces
chronic bacteremia and can seed Bartonella blood-culture-negative
endocarditis.
biological_processes:
- preferred_term: biological process involved in interaction with host
modifier: INCREASED
term:
id: GO:0051701
label: biological process involved in interaction with host
evidence:
- reference: PMID:16494745
reference_title: Bartonella quintana characteristics and clinical management.
supports: SUPPORT
evidence_source: OTHER
snippet: >-
It is now recognized as a reemerging pathogen among homeless populations in
cities in the United States and Europe and is responsible for a wide
spectrum of conditions, including chronic bacteremia, endocarditis, and
bacillary angiomatosis.
explanation: >-
The review supports chronic bacteremia and endocarditis as core systemic
B. quintana manifestations.
downstream:
- target: Chronic Bacteremia
description: Persistent blood infection is the defining manifestation of this branch.
- target: Bacterial Endocarditis
description: Chronic bacteremia can seed bacterial endocarditis.
- target: Chronic Lymphadenopathy
description: Chronic B. quintana infection can produce chronic lymphadenopathy.
- target: Vomp-Mediated Endothelial Adherence
description: >-
Circulating B. quintana adheres to vascular endothelium, the step that
precedes the vasoproliferative branch.
causal_link_type: INDIRECT_KNOWN_INTERMEDIATES
- name: Vomp-Mediated Endothelial Adherence
description: >-
Variably expressed outer membrane proteins (Vomps), the trimeric
autotransporter adhesins of B. quintana, mediate adherence to extracellular
matrix and endothelial cells, the adhesion step upstream of the
pro-angiogenic endothelial response.
cell_types:
- preferred_term: endothelial cell
term:
id: CL:0000115
label: endothelial cell
evidence:
- reference: PMID:21536788
reference_title: "Trimeric autotransporter adhesin-dependent adherence of Bartonella henselae, Bartonella quintana, and Yersinia enterocolitica to matrix components and endothelial cells under static and dynamic flow conditions."
supports: SUPPORT
evidence_source: IN_VITRO
snippet: >-
Under static conditions, ECM adherence of B. henselae, B. quintana, and Y.
enterocolitica was strongly dependent on the expression of their particular
TAAs.
explanation: >-
B. quintana ECM adherence was strongly dependent on its trimeric
autotransporter adhesins (Vomps), the adhesion step this node captures.
- reference: PMID:21536788
reference_title: "Trimeric autotransporter adhesin-dependent adherence of Bartonella henselae, Bartonella quintana, and Yersinia enterocolitica to matrix components and endothelial cells under static and dynamic flow conditions."
supports: SUPPORT
evidence_source: IN_VITRO
quote_role: BACKGROUND
snippet: >-
Trimeric autotransporter adhesins (TAAs) are important virulence factors of
Gram-negative bacteria responsible for adherence to extracellular matrix
(ECM) and host cells.
explanation: >-
Background on the trimeric-autotransporter-adhesin class to which the B.
quintana Vomps belong.
downstream:
- target: BafA-Driven Endothelial VEGF Signaling
description: >-
Endothelial adherence positions B. quintana to drive the BafA/VEGF
pro-angiogenic response.
causal_link_type: INDIRECT_KNOWN_INTERMEDIATES
- name: BafA-Driven Endothelial VEGF Signaling
description: >-
Bartonella BafA acts as a VEGF receptor 2 ligand; the B. quintana BafA
homolog is functional, supporting a homologous pro-angiogenic route into
endothelial proliferation in B. quintana-associated bacillary angiomatosis.
cell_types:
- preferred_term: endothelial cell
term:
id: CL:0000115
label: endothelial cell
biological_processes:
- preferred_term: positive regulation of angiogenesis
modifier: INCREASED
term:
id: GO:0045766
label: positive regulation of angiogenesis
evidence:
- reference: PMID:32678094
reference_title: >-
The Bartonella autotransporter BafA activates the host VEGF pathway to
drive angiogenesis.
supports: SUPPORT
evidence_source: IN_VITRO
snippet: >-
BafA interacts with vascular endothelial growth factor (VEGF) receptor-2
and activates the downstream signaling pathway, suggesting that BafA
functions as a VEGF analog.
explanation: >-
Identifies the Bartonella autotransporter mechanism that activates VEGFR2
signaling and drives endothelial angiogenic responses.
- reference: PMID:32678094
reference_title: >-
The Bartonella autotransporter BafA activates the host VEGF pathway to
drive angiogenesis.
supports: SUPPORT
evidence_source: IN_VITRO
snippet: >-
A BafA homolog from a related pathogen, Bartonella quintana, is also
functional.
explanation: >-
Extends the BafA functional observation to the B. quintana homolog.
downstream:
- target: Bacillary Angiomatosis
description: >-
Pro-angiogenic endothelial signaling is a molecular route into
vasoproliferative bacillary angiomatosis.
evidence:
- reference: PMID:9407154
reference_title: >-
Molecular epidemiology of bartonella infections in patients with
bacillary angiomatosis-peliosis.
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
Of the 49 patients with bacillary angiomatosis-peliosis, 26 (53 percent)
were infected with B. henselae and 23 (47 percent) with B. quintana.
explanation: >-
Human molecular epidemiology connects B. quintana infection with
bacillary angiomatosis-peliosis lesions.
- name: Bartonella Intracellular Persistence
description: >-
B. quintana is an intracellular Bartonella pathogen; residence inside host
cells constrains treatment toward cell-penetrant antimicrobials such as
doxycycline.
role: intrinsic_resistance
conforms_to: "intracellular_pathogen_persistence#Intracellular Niche and Beta-Lactam Exclusion"
biological_processes:
- preferred_term: Biological Process Involved in Interaction with Host
term:
id: GO:0051701
label: biological process involved in interaction with host
evidence:
- reference: PMID:18611821
reference_title: Intracellular organisms.
supports: SUPPORT
evidence_source: OTHER
snippet: >-
The intracellular location of some microorganisms allow them to resist
antibiotics with poor ability to penetrate eukaryotic cell membranes, such
as the beta-lactam compounds.
explanation: >-
Review evidence for the intracellular-niche principle behind
cell-penetrant antimicrobial selection.
- name: Bartonella Ribosomal Translation
description: >-
B. quintana depends on bacterial 70S ribosomal translation; doxycycline and
gentamicin both act on the bacterial 30S ribosomal subunit.
role: therapeutic_vulnerability
conforms_to: "bacterial_protein_synthesis_inhibition#Bacterial mRNA Translation by the Ribosome"
biological_processes:
- preferred_term: translation
term:
id: GO:0006412
label: translation
evidence:
- reference: PMID:24336183
reference_title: Ribosome-targeting antibiotics and mechanisms of bacterial resistance.
supports: SUPPORT
evidence_source: OTHER
snippet: >-
The ribosome is one of the main antibiotic targets in the bacterial cell.
explanation: >-
Review establishing the bacterial ribosome as the target of
protein-synthesis inhibitors, the drug-target node represented here.
phenotypes:
- name: Fever
description: >-
High fever is the cardinal feature of the acute trench-fever syndrome,
classically with a relapsing five-day (quintan) periodicity.
phenotype_term:
preferred_term: Fever
term:
id: HP:0001945
label: Fever
evidence:
- reference: PMID:16494745
reference_title: Bartonella quintana characteristics and clinical management.
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
quote_role: REVIEW_SYNTHESIS
snippet: >-
The first was characterized by a sudden onset of headache, dizziness, pain
in the shins, and elevated temperature
explanation: Elevated temperature (fever) is a cardinal acute trench-fever feature.
- name: Headache
description: Sudden-onset headache is part of the acute trench-fever syndrome.
phenotype_term:
preferred_term: Headache
term:
id: HP:0002315
label: Headache
evidence:
- reference: PMID:16494745
reference_title: Bartonella quintana characteristics and clinical management.
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
quote_role: REVIEW_SYNTHESIS
snippet: >-
The first was characterized by a sudden onset of headache, dizziness, pain
in the shins, and elevated temperature
explanation: Sudden headache is part of the acute trench-fever syndrome.
- name: Bone pain
description: >-
Pain in the shins (tibial bone pain) is the classic musculoskeletal feature
that gives trench fever the name "shin bone fever".
phenotype_term:
preferred_term: Shin (tibial) bone pain
term:
id: HP:0002653
label: Bone pain
evidence:
- reference: PMID:16494745
reference_title: Bartonella quintana characteristics and clinical management.
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
quote_role: REVIEW_SYNTHESIS
snippet: >-
The first was characterized by a sudden onset of headache, dizziness, pain
in the shins, and elevated temperature
explanation: Pain in the shins is the characteristic tibial bone pain of trench fever.
- name: Chronic Bacteremia
description: B. quintana can cause persistent blood infection.
phenotype_term:
preferred_term: Bacteremia
term:
id: HP:0031864
label: Bacteremia
evidence:
- reference: PMID:12821469
reference_title: >-
Randomized open trial of gentamicin and doxycycline for eradication of
Bartonella quintana from blood in patients with chronic bacteremia.
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
Chronic Bartonella quintana bacteremia is known to occur in homeless
people exposed to lice.
explanation: >-
Human trial report establishes chronic B. quintana bacteremia as a
clinical manifestation after louse exposure.
- name: Bacterial Endocarditis
description: >-
B. quintana is an important cause of blood-culture-negative bacterial
endocarditis.
phenotype_term:
preferred_term: Bacterial endocarditis
term:
id: HP:0006689
label: Bacterial endocarditis
evidence:
- reference: PMID:15891120
reference_title: High prevalence of Bartonella quintana endocarditis in Sfax, Tunisia.
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
Bartonella quintana is a fastidious microorganism associated with blood
culture negative endocarditis.
explanation: >-
Human endocarditis serology/PCR study identifies B. quintana as a
blood-culture-negative endocarditis organism.
- name: Chronic Lymphadenopathy
description: >-
Chronic adenomegaly or lymphadenopathy can occur with B. quintana infection,
including in seronegative disease.
phenotype_term:
preferred_term: Lymphadenopathy
temporality: CHRONIC
term:
id: HP:0002716
label: Lymphadenopathy
evidence:
- reference: PMID:8727894
reference_title: Bartonella (Rochalimaea) quintana infection in a seronegative hemodialyzed patient.
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
Chronic adenomegaly in seronegative patients is a new clinical entity due
to B. quintana.
explanation: >-
Human case evidence supports chronic adenomegaly as a lymphadenopathy
presentation of B. quintana infection.
- name: Bacillary Angiomatosis
description: >-
B. quintana is one molecularly typed cause of bacillary
angiomatosis-peliosis in immunocompromised patients. No HP term for
bacillary angiomatosis exists (OLS HP search "l~angiomatosis" returns only
cystic angiomatosis of bone and visceral angiomatosis, neither of which
fits), so no phenotype_term is bound.
evidence:
- reference: PMID:9407154
reference_title: >-
Molecular epidemiology of bartonella infections in patients with bacillary
angiomatosis-peliosis.
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
Of the 49 patients with bacillary angiomatosis-peliosis, 26 (53 percent)
were infected with B. henselae and 23 (47 percent) with B. quintana.
explanation: >-
Human molecular epidemiology identifies B. quintana in nearly half of a
bacillary angiomatosis-peliosis cohort.
diagnosis:
- name: Serology and PCR for blood-culture-negative endocarditis
description: >-
Because B. quintana is fastidious and blood-culture-negative, diagnosis
relies on serology and molecular detection (nested PCR of target genes)
rather than routine culture.
diagnosis_term:
preferred_term: serology and nested PCR for Bartonella
term:
id: NCIT:C17003
label: Polymerase Chain Reaction
evidence:
- reference: PMID:15891120
reference_title: High prevalence of Bartonella quintana endocarditis in Sfax, Tunisia.
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
These sera were also positive by LightCycler nested PCR amplification for
the rnpb (7 of 13) and fur (11 of 13) genes.
explanation: Nested PCR of the rnpB and fur genes on sera confirmed B. quintana in culture-negative endocarditis.
prevalence:
- population: Homeless people, Marseilles
measure_type: POINT_PREVALENCE
prevalence_class: ABOVE_1_IN_1000
rate_per_100000: 5300.0
notes: >-
B. quintana bacteremia was detected in 5.3% of 930 homeless people in
Marseilles; the disease is concentrated in, not rare within, this cohort.
evidence:
- reference: PMID:15643300
reference_title: "Ectoparasitism and vector-borne diseases in 930 homeless people from Marseilles."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
Bartonella quintana was isolated from blood culture in 50 patients (5.3%),
36 of whom were treated effectively
explanation: B. quintana bacteremia was found in 5.3% of a 930-person homeless cohort.
treatments:
- name: Doxycycline Plus Gentamicin
description: >-
Combination therapy with doxycycline and gentamicin eradicates chronic
B. quintana bacteremia in randomized-trial data.
treatment_term:
preferred_term: Pharmacotherapy
term:
id: NCIT:C15986
label: Pharmacotherapy
therapeutic_agent:
- preferred_term: doxycycline
term:
id: CHEBI:50845
label: doxycycline
- preferred_term: gentamicin
term:
id: CHEBI:759884
label: gentamicin
therapeutic_modality: SMALL_MOLECULE
target_mechanisms:
- target: Bartonella Intracellular Persistence
description: >-
Doxycycline has intracellular activity suited to Bartonella organisms in
host-cell niches.
- target: Bartonella Ribosomal Translation
description: >-
Doxycycline and gentamicin inhibit bacterial ribosomal protein synthesis.
evidence:
- reference: PMID:12821469
reference_title: >-
Randomized open trial of gentamicin and doxycycline for eradication of
Bartonella quintana from blood in patients with chronic bacteremia.
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
This study demonstrates the efficiency of the combination of doxycycline
and gentamicin in eradicating B. quintana bacteremia.
explanation: >-
Randomized trial evidence supports doxycycline plus gentamicin for chronic
B. quintana bacteremia.
- reference: PMID:23602630
reference_title: "Treatment outcomes of human bartonellosis: a systematic review and meta-analysis."
supports: SUPPORT
evidence_source: OTHER
snippet: >-
In chronic bacteremia, gentamicin and doxycycline significantly increased
the resolution rate.
explanation: >-
Systematic-review evidence independently supports this combination for
chronic Bartonella bacteremia.
Deep research results are used as seeds for research; they do not undergo the same validation as the main records and may contain errors. How we use deep research.
Create: Trench Fever · 2026-09-25T07:03:33Z · View source
Created a Trench Fever infectious-disease entry grounded in an OpenScientist deep-research report for MONDO:0005991. Added Bartonella quintana as the infectious agent, body-louse fecal transmission, progression phases, erythrocyte-colonization and vasoproliferative pathophysiology, chronic bacteremia/endocarditis/lymphadenopathy/bacillary angiomatosis phenotypes, and doxycycline plus gentamicin pharmacotherapy targeting intracellular persistence and bacterial ribosomal translation. Verified the deep-research report with preflight-dr before curation, resolved ontology bindings through OAK/validate-terms, copied reference titles from cache frontmatter, and validated exact snippets against cached PMID records.
Disease: Trench Fever · MONDO ID: MONDO:0005991 · Category: Infectious Disease Causal agent: Bartonella quintana (α-proteobacteria; formerly Rochalimaea quintana) ICD-10: A79.0 · ICD-11: 1C30.0 · MeSH: D014205 (Trench Fever) Evidence base: aggregated disease-level literature (reviews, case-control studies, one randomized trial, experimental microbiology). No individual EHR or genomic data files were provided; this report synthesizes primary literature retrieved via PubMed (27 papers reviewed, 11 findings confirmed).
Trench fever is a louse-borne bacterial infection caused by Bartonella quintana, a small, fastidious, facultatively intracellular α-proteobacterium that is restricted to a single natural reservoir — humans — and a single principal vector, the human body louse (Pediculus humanus humanus). First characterized in 1915 among soldiers in the trenches of World War I (hence the name), the disease has re-emerged over the past three decades as "urban trench fever" among homeless and socially marginalized populations in high-income cities in the US and Europe (PMID: 16494745). It is fundamentally a disease of poverty and body-louse infestation, not a genetic disease; there are no known human causal genes, susceptibility loci, or heritable risk factors.
Clinically, B. quintana produces a broad spectrum running from the classic self-limited relapsing febrile illness ("five-day fever," with headache and severe shin/tibial bone pain) through chronic afebrile bacteremia, blood-culture-negative endocarditis, chronic lymphadenopathy, and — particularly in immunocompromised hosts such as people with HIV — the vasoproliferative disorders bacillary angiomatosis and peliosis (PMID: 16494745; PMID: 15891120). Two mechanistic axes dominate the pathophysiology: (1) the laterally acquired Trw type IV secretion system (T4SS) mediates host-specific adhesion to and invasion of erythrocytes, producing the hallmark long-lasting intraerythrocytic bacteremia; and (2) a suite of factors — the Vomps trimeric autotransporter adhesins, the VirB/VirD4 T4SS with its Bep effectors, and the BafA autotransporter (a VEGF analog) — converge on HIF-1/VEGF signaling to drive endothelial proliferation, tube formation, and angiogenesis (PMID: 20548954; PMID: 32678094; PMID: 21536788; PMID: 23163798).
Diagnosis rests on serology, blood culture (often prolonged), and molecular detection (PCR of gltA/ftsZ/16S rRNA). The best-supported treatment for chronic bacteremia is doxycycline plus gentamicin, validated by a randomized open trial (eradication in 7/7 per-protocol treated vs 2/9 controls, P=0.003) (PMID: 12821469) and a systematic review/meta-analysis (PMID: 23602630). Prevention is fundamentally body-louse control and improved hygiene/social conditions; there is no vaccine. This report synthesizes 11 confirmed findings across all 15 template sections.
Bartonella quintana is an α-proteobacterium (formerly Rochalimaea quintana) whose lifestyle is restricted to human hosts and louse vectors. It was the first Bartonella species definitively linked to human disease and was characterized as the agent of trench fever, a disease "described in 1915 on the basis of natural and experimental infections in soldiers" (PMID: 16494745). After decades of relative obscurity, it re-emerged as a pathogen of the urban homeless: in a study of homeless persons, B. quintana was isolated from blood culture in 5.3% of patients (PMID: 15643300).
The verbatim evidence: "Bartonella quintana, a pathogen that is restricted to human hosts and louse vectors, was first characterized as the agent of trench fever. The disease was described in 1915 on the basis of natural and experimental infections in soldiers" (PMID: 16494745).
Key identifiers: MONDO:0005991; ICD-10 A79.0; ICD-11 1C30.0; MeSH D014205. This is an infectious, aggregated disease-level entity — knowledge is derived from case series, cohort studies, microbiology, and molecular biology, not from Mendelian/EHR genetic resources (no OMIM/Orphanet gene entry applies because it is not heritable). Common synonyms: five-day fever, quintan fever, His-Werner disease, shin bone fever, wolhynia fever, urban trench fever.
B. quintana is "responsible for a wide spectrum of conditions, including chronic bacteremia, endocarditis, and bacillary angiomatosis" (PMID: 16494745). The classic acute syndrome is a relapsing fever recurring at ~5-day intervals ("quintana" = fifth), with headache, dizziness, and characteristic severe pain in the shins/tibiae. Beyond the acute illness, chronic afebrile bacteremia can persist for months; endocarditis is an important severe outcome. In a series from Sfax, Tunisia, B. quintana endocarditis "represents 9.8% of all endocarditis" in that setting, with high IgG titers (≥1:800) supporting the diagnosis (PMID: 15891120). Chronic infection can also present as isolated lymphadenopathy/adenomegaly, including in seronegative patients (PMID: 8727894). In immunocompromised hosts (notably HIV), the organism drives vasoproliferative disease — bacillary angiomatosis and peliosis.
| Clinical syndrome | Host context | Key features | HPO/phenotype terms |
|---|---|---|---|
| Classic trench fever | Immunocompetent | Relapsing 5-day fever, headache, severe shin/bone pain | Fever HP:0001945; Headache HP:0002315; Bone pain HP:0002653 |
| Chronic afebrile bacteremia | Homeless, louse-exposed | Persistent intraerythrocytic bacteremia | Bacteremia HP:0031864 |
| Blood-culture-negative endocarditis | Valvulopathy/chronic infection | Vegetations, high IgG titers; may need valve surgery | Endocarditis HP:0100584 |
| Chronic lymphadenopathy | Sometimes seronegative | Adenomegaly | Lymphadenopathy HP:0002716 |
| Bacillary angiomatosis / peliosis | Immunocompromised (HIV) | Vasoproliferative skin/bone/visceral lesions | Cutaneous vascular lesions |
Two experimentally demonstrated virulence mechanisms anchor the pathophysiology.
(1) Erythrocyte invasion via the Trw T4SS. Using signature-tagged mutagenesis in surrogate Bartonella species, the Trw type IV secretion system was shown to be directly involved in erythrocyte adhesion; its genes "encode components of the type IV secretion system (T4SS) Trw, demonstrating that this virulence factor laterally acquired by the Bartonella lineage is directly involved in adherence to erythrocytes" (PMID: 20548954). This host-specific adhesion enables the hallmark long-lasting intraerythrocytic bacteremia.
(2) VEGF-driven vasoproliferation via BafA. The Bartonella autotransporter BafA acts as a VEGF analog: "BafA interacts with vascular endothelial growth factor (VEGF) receptor-2 and activates the downstream signaling pathway, suggesting that BafA functions as a VEGF analog. A BafA homolog from a related pathogen, Bartonella quintana, is also functional" (PMID: 32678094). This explains the vasoproliferative lesions (bacillary angiomatosis) directly at the molecular level.
The best-supported regimen for chronic B. quintana bacteremia is doxycycline plus gentamicin. A randomized open trial (Foucault, Raoult, Brouqui 2003) in homeless patients with blood-culture-positive B. quintana compared gentamicin 3 mg/kg/day IV for 14 days + doxycycline 200 mg/day orally for 28 days versus no treatment. "Intention-to-treat analysis of 20 included patients showed eradication of bacteremia in 7 out of 9 treated patients versus 2 out of 11 untreated controls (P = 0.01). In the per-protocol analysis, eradication was obtained for 7 out of 7 treated patients versus 2 out of 9 untreated controls (P = 0.003)" (PMID: 12821469).
A systematic review and meta-analysis of human bartonellosis treatment corroborates this: "In chronic bacteremia, gentamicin and doxycycline significantly increased the resolution rate" (PMID: 23602630) — though the authors note the evidence base is limited and dominated by observational studies at high risk of bias. Expert-guideline regimens (Rolain et al. 2004) extend this: endocarditis typically requires prolonged therapy (often doxycycline + an aminoglycoside) and may require valve surgery; bacillary angiomatosis responds to macrolides (erythromycin) or doxycycline given for months. NCIT term suggestions: Doxycycline (NCIT:C692), Gentamicin (NCIT:C575), Erythromycin (NCIT:C608).
Comparative genomics of the genus shows Bartonella are α-proteobacteria with host-restricted lifestyles characterized by long-lasting intraerythrocytic infection in a specific mammalian reservoir and arthropod transmission. Among sequenced genomes (circular chromosomes 1.44–2.62 Mb; 1,283–2,136 genes; a synthenic core of 959 genes), B. quintana underwent "massive secondary genome reduction" — it has the smallest genome (~1.58 Mb, ~1,300 genes) — consistent with adaptation to a single human host plus louse vector (PMID: 19696500). The type IV secretion systems (Trw, VirB/VirD4) were laterally acquired and are "type IV secretion systems that adopted prominent roles in host adaptation and specificity" (PMID: 19696500). This reductive evolution reflects the pathogen's dependence on host-derived metabolites (host-integrated metabolism) and its narrow ecological niche.
A case-control study of 49 HIV-associated bacillary angiomatosis-peliosis patients versus 96 matched controls found that 23/49 (47%) were B. quintana and 26/49 (53%) B. henselae. Crucially, tissue tropism differed by species: "Subcutaneous and lytic bone lesions were strongly associated with B. quintana, whereas peliosis hepatis was associated exclusively with B. henselae" (PMID: 9407154). Risk factors also segregated: patients "with B. quintana were clustered and were characterized by low income (P=0.003), homelessness (P = 0.004), and exposure to lice (P= 0.03)", whereas B. henselae was tied to cat/flea exposure (PMID: 9407154). This confirms both the skin/bone tissue tropism of B. quintana and its socioeconomic risk profile.
Humans acquire B. quintana through contaminated body-louse feces, not the louse bite directly: "Horizontal transmission from the body louse vector (Pediculus humanus humanus) to a human host occurs through contact with infectious louse feces containing a high concentration of the bacteria" — typically inoculated into skin abrasions or bite-scratch excoriations (PMID: 35803580). Controlled experiments testing vertical transmission found bacterial DNA on egg surfaces (fecal contamination of the egg sheath) but no viable organisms internally: "viable B. quintana could not be cultured from the hemolymph of adult female lice or from within eggs that were surface sterilized, indicating a lack of true transovarial transmission" (PMID: 35803580). Vertical transfer therefore "probably has a limited impact on the dynamics of transmission to humans." This has direct public-health implications: interrupting the human↔louse cycle (delousing) breaks transmission.
B. quintana expresses variably expressed outer membrane proteins (Vomps), which are trimeric autotransporter adhesins (TAAs) analogous to B. henselae's Bartonella adhesin A (BadA). In a study of adherence under static and bloodstream-like dynamic flow, investigators "analyzed three different TAAs (Bartonella adhesin A [BadA] of Bartonella henselae, variably expressed outer membrane proteins [Vomps] of Bartonella quintana, and Yersinia adhesin A [YadA] of Yersinia enterocolitica) for mediating bacterial adherence to ECM and endothelial cells" (PMID: 21536788) — establishing Vomps as B. quintana's ECM/endothelial adhesins (binding fibronectin, collagen).
Mechanistically, in the closely related B. henselae the pathway is well defined: "Expression of Bartonella adhesin A (BadA) is crucial for bacterial autoagglutination, adhesion to host cells, binding to extracellular matrix proteins and proangiogenic reprogramming via activation of hypoxia inducible factor (HIF)-1" (PMID: 18627378). In parallel, the VirB/VirD4 T4SS delivers effector proteins into endothelial cells: "VirB/D4 translocates several Bartonella effector proteins (Beps) into the cytoplasm of infected ECs, resulting, e.g. in uptake of bacterial aggregates via the invasome structure, inhibition of apoptosis and activation of a proangiogenic phenotype" (PMID: 23163798). Notably, BadA and VirB/D4 are frequently mutually exclusive during in vitro passage — a phase-variation phenomenon relevant to culture-dependent diagnostics.
The natural reservoir of B. quintana is humans (NCBI Taxon 9606), transmitted by the body louse. However, molecular surveys increasingly detect B. quintana DNA in non-human hosts. A survey of pet cats in Urmia, Iran found "15 % of the cats (30 out of 200 blood samples) tested positive for the B. quintana gene, with a 95 % confidence interval of 10.71 % to 20.61 %" (100% sequence identity to the reference) (PMID: 38199070). For comparative disease modeling, dogs develop naturally occurring Bartonella endocarditis, making "canids... the most interesting naturally occurring animal model for the human disease" (PMID: 12860639). Experimental mechanistic work uses surrogate rodent-adapted species — "mouse-specific Bartonella birtlesii, human-specific Bartonella quintana, cat-specific Bartonella henselae and rat-specific Bartonella tribocorum" in adhesion/invasion assays (PMID: 20548954) — and the body louse itself serves as an in-vivo vector model.
In a 4-year study of 930 homeless people in Marseilles, lice were found in 22%, and B. quintana was isolated from blood culture in 50 (5.3%); critically, "the number of bacteremic patient increased from 3.4% to 8.4% (p = 0.02) over the 4 years of the study" — evidence of a rising trend (PMID: 15643300). Geographically, the pathogen is cosmopolitan wherever body-louse infestation occurs: a molecular survey of body lice detected "the presence of B. quintana in lice collected from all locations except the Congo" — spanning France, Russia, Peru, Zimbabwe, and Burundi (PMID: 9986818). B. quintana is one of only three body-louse-borne human pathogens, alongside Rickettsia prowazekii (epidemic typhus) and Borrelia recurrentis (louse-borne relapsing fever); co-exposure occurs, with documented R. prowazekii seroconversion in a B. quintana-bacteremic homeless person (PMID: 15891141).
1. Body louse (Pediculus humanus humanus) feeds on a bacteremic human
│ leads to
2. B. quintana replicates in the louse gut and is shed in LOUSE FECES
(high bacterial concentration; NOT transovarial — no vertical spread)
│ results in
3. Contaminated feces inoculated into skin abrasions / bite-scratch
excoriations of a new human host (horizontal transmission)
│ leads to
4. Bacteria seed a primary niche (endothelial cells / dermal tissue)
│ then (via Trw T4SS)
5. Trw type IV secretion system mediates HOST-SPECIFIC ADHESION to and
INVASION of erythrocytes
│ results in
6. Long-lasting INTRAERYTHROCYTIC BACTEREMIA (immune-privileged niche;
enables relapsing fever + chronic bacteremia + louse re-acquisition)
│
├─► BRANCH A (acute/chronic systemic disease):
│ relapsing 5-day fever, headache, severe shin/bone pain;
│ chronic afebrile bacteremia → endocarditis (valve
│ vegetations, culture-negative)
│
└─► BRANCH B (vasoproliferative disease, esp. immunocompromised):
Vomps (TAAs) adhere to ECM (fibronectin/collagen) + endothelium
│ + VirB/D4 T4SS translocates Bep effectors
│ + BafA autotransporter binds VEGFR-2 (VEGF analog)
│ results in
HIF-1 activation → VEGF secretion (autocrine/paracrine loop)
inhibition of endothelial apoptosis; invasome-mediated uptake
│ leads to
ENDOTHELIAL PROLIFERATION → tube formation → ANGIOGENESIS
│ results in
Bacillary angiomatosis (skin, LYTIC BONE lesions),
vasoproliferative tumors
Upstream vs downstream. The initiating lesion is environmental/behavioral (louse infestation + poverty), not genetic. The most upstream molecular event in host colonization is Trw-mediated erythrocyte tropism, which sustains the bacteremic reservoir. The vasoproliferative arm is downstream of endothelial adhesion (Vomps/BadA) and effector delivery (VirB/D4-Bep, BafA), all converging on the HIF-1 → VEGF hub. Note that Trw (erythrocyte invasion) and VirB/D4 (endothelial reprogramming) are distinct T4SSs with distinct target cells. The HIF-1/VEGF steps are directly demonstrated for B. henselae BadA and inferred for B. quintana via its homologous Vomps and functional BafA homolog.
Cell types and processes (ontology suggestions). - Erythrocyte (CL:0000232) — intracellular niche; GO:0007155 cell adhesion; GO:0044409 entry into host. - Endothelial cell (CL:0000115) — angiogenesis target; GO:0001525 angiogenesis; GO:0043066 negative regulation of apoptotic process; GO:0001666 response to hypoxia (HIF-1). - Anatomical sites (UBERON): blood (UBERON:0000178), skin/dermis (UBERON:0002067), bone (UBERON:0001474), heart valve/endocardium (UBERON:0002165), lymph node (UBERON:0000029), liver (peliosis, mainly B. henselae; UBERON:0002107). - Chemical/biomarker entities (CHEBI): doxycycline (CHEBI:50845); gentamicin (CHEBI:27412).
| Feature | B. quintana (trench fever) | B. henselae (cat-scratch) |
|---|---|---|
| Reservoir / vector | Human / body louse | Cat / cat flea |
| Adhesin (TAA) | Vomps | BadA |
| Risk factors | Homelessness, poverty, lice | Cat contact, flea exposure |
| BA tissue tropism | Subcutaneous + lytic bone lesions | Peliosis hepatis |
| Genome | ~1.58 Mb (most reduced) | ~1.9 Mb |
| PMID | Title (abbrev.) | Supports finding(s) | Contribution |
|---|---|---|---|
| 16494745 | B. quintana characteristics and clinical management | F1, F2 | Causal agent, host/vector restriction, 1915 origin, clinical spectrum, diagnostics |
| 15643300 | Ectoparasitism... 930 homeless, Marseilles | F1, F11 | 5.3% bacteremia; rising 3.4%→8.4%; 22% louse prevalence |
| 20548954 | Trw T4SS mediates host-specific RBC adhesion | F3, F9 | Trw T4SS = erythrocyte invasion; surrogate species models |
| 32678094 | BafA activates host VEGF pathway | F3 | BafA = VEGF analog binding VEGFR-2; B. quintana homolog functional |
| 15891120 | High prevalence of B. quintana endocarditis, Sfax | F2 | Endocarditis burden (9.8% of all endocarditis) |
| 23602630 | Treatment outcomes of human bartonellosis (meta-analysis) | F4 | Doxy+gentamicin ↑ resolution of chronic bacteremia |
| 12821469 | Randomized trial gentamicin+doxycycline | F10 | RCT: 7/7 vs 2/9 eradication (P=0.003) |
| 19696500 | Genomics of host-restricted Bartonella | F5 | Massive secondary genome reduction; T4SS host adaptation |
| 9407154 | Molecular epidemiology of bacillary angiomatosis | F6 | Skin/bone tropism; low income/homeless/lice associations |
| 35803580 | Vertical transmission in body lice | F7 | Horizontal fecal transmission; no transovarial spread |
| 21536788 | TAA-dependent adherence under flow | F8 | Vomps = B. quintana TAA; ECM/endothelial adhesion |
| 23163798 | BadA interferes with VirB/D4 effector translocation | F8 | VirB/D4-Bep proangiogenic, anti-apoptotic reprogramming |
| 18627378 | BadA head crucial for host cell interaction | F8 | TAA adhesion → HIF-1 activation |
| 38199070 | B. quintana in pet cats, Iran | F9 | 15% cat detection — expanding host range |
| 12860639 | Persistent Bartonella bacteremia in humans/animals | F9 | Dogs as natural endocarditis model |
| 9986818 | Body lice as tools for surveillance | F11 | Worldwide distribution in lice |
| 15891141 | Autochthonous epidemic typhus + B. quintana | F11 | Co-circulation of louse-borne pathogens |
| 20822446 | Arthropod-borne diseases & social disorder | F4 (prevention) | Vector control as primary prevention |
| 11871479 | Infections in the homeless | F1, F6 | Homeless disease context |
| 8727894 | B. quintana in seronegative hemodialyzed patient | F2 | Chronic adenomegaly; seronegative presentation; gentamicin response |
Mechanistic inference across species. Much of the vasoproliferative signaling detail (HIF-1 activation, VirB/D4-Bep effector biology, BadA structure–function) is demonstrated in B. henselae and inferred for B. quintana via the homologous Vomps/BafA systems. Direct B. quintana endothelial-reprogramming studies are comparatively sparse. The BafA VEGFR-2 interaction was shown functional for the B. quintana homolog, but the full downstream cascade in B. quintana is extrapolated.
Treatment evidence is thin. The pivotal RCT enrolled only 20 patients (PMID: 12821469), and the meta-analysis explicitly flags that most treatment evidence is observational and at high risk of bias (PMID: 23602630). Optimal duration for endocarditis, and management of relapse, remain guideline/expert-opinion driven.
Epidemiology is likely underestimated. Fastidious culture requirements and non-specific clinical presentation mean cases are under-ascertained; prevalence figures derive largely from urban homeless cohorts in France and may not generalize globally. Population-level incidence rates (new cases/100,000/yr) are not well established.
Expanding host range uncertain in significance. Detection of B. quintana DNA in cats, dogs, non-human primates, and other animals (PMID: 38199070) raises the question of whether animals are competent reservoirs or incidental/spillover hosts. Whether these represent transmission risk to humans is unresolved.
No human genetic component — the template's genetic/variant/inheritance/heritable-model sections are not applicable; any "susceptibility" is socioeconomic and behavioral, not genomic.
Quality-of-life and disability data specific to trench fever (EQ-5D, SF-36, PROMIS) are essentially absent in the literature; QoL impact is inferred from the burden of chronic bacteremia/endocarditis and the comorbidities of the affected homeless population.
Direct B. quintana vasoproliferation assays. Test purified B. quintana BafA and Vomps in human endothelial cells for HIF-1 stabilization, VEGF secretion, tube formation, and apoptosis inhibition — to replace B. henselae inference with species-specific data.
Larger, multicenter treatment trial. A pragmatic RCT (or well-designed prospective registry) across multiple homeless-service settings to define the optimal antibiotic regimen and duration for chronic bacteremia and endocarditis, and to quantify relapse.
Global surveillance via body lice. Extend the molecular-surveillance approach (PMID: 9986818) to systematically map B. quintana prevalence in body lice and homeless populations worldwide, including incidence estimation.
Reservoir-competence studies in animals. Determine whether cats/dogs/primates with detectable B. quintana DNA harbor viable, transmissible bacteria and whether alternative arthropod vectors participate — clarifying zoonotic risk.
Public-health intervention evaluation. Rigorously evaluate delousing/hygiene/housing interventions for their effect on B. quintana incidence, integrating vector control per PMID: 20822446.
Biomarker/diagnostic development. Develop rapid point-of-care serologic or molecular assays suited to low-resource, homeless-service settings to improve case ascertainment and shorten time-to-treatment.
Trench fever is a louse-borne bacterial infection caused by Bartonella quintana (MONDO:0005991; ICD-10 A79.0), a human-restricted α-proteobacterium transmitted through the feces of the body louse (Pediculus humanus humanus) and re-emerging among the urban homeless worldwide. It is not a genetic disease — risk is socioeconomic (homelessness, poverty, body lice, poor hygiene; immunosuppression for vasoproliferative forms) — and it spans a clinical spectrum from classic relapsing five-day fever with shin pain to chronic bacteremia, culture-negative endocarditis, and bacillary angiomatosis, driven mechanistically by Trw-T4SS–mediated erythrocyte invasion plus Vomps/BadA-, VirB/D4-Bep–, and BafA-driven HIF-1/VEGF endothelial proliferation. It is effectively treated with doxycycline plus gentamicin (randomized-trial evidence) and prevented by body-louse control; no vaccine exists.
Checked with linkml-reference-validator 0.3.0rc1.
| Outcome | Count |
|---|---|
| References checked | 20 |
| Resolved | 20 |
| Unresolved (possible confabulation) | 0 |
| Unverifiable | 0 |
| References weighed for topical relevance | 20 |
| On topic | 15 |
| Off topic | 0 |
All extracted references resolved successfully.
Checked with linkml-term-validator 0.4.5, through the ols: adapter.
| Outcome | Count |
|---|---|
| Terms checked | 26 |
| Resolved | 26 |
| Unresolved (possible confabulation) | 0 |
| Obsolete | 0 |
| Unverifiable | 0 |
| Terms whose name was checked | 5 |
| Terms named correctly | 2 |
| Terms named as a different term | 3 |
These identifiers resolve, so nothing about them looks wrong, and the ontology calls them something unrelated to what the report calls them. That usually means the identifier is not the one the sentence needs:
MONDO:0005991 (5 mentions) - the report calls it "if available"; MONDO calls it trench feverHP:0001945 (2 mentions) - the report calls it "relapsing, ~5-day periodicity"; HP calls it FeverHP:0002653 (2 mentions) - the report calls it "shin/tibia"; HP calls it Bone pain